ARCHIVES

FDA: Oncology Division Director Delap Promoted In Agency

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003

Cigarette use declining among high school students, report finds.

June 25, 2004

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004